ReGENIN® S
Anti-Cellulite Amplue, Best Cellulite Expert, Next Generation Peptide
Experimental Data
Double Chin Lifting Volume Improvement
Double Chin Lifting Effect (Volume)
Clinical Trial Results
20.5%
Facial Area (Double Chin) 8 weeks of use
Average age of clinical trial participants: 40 years oldBefore use
After 4 weeks
After 8 weeks
Before use
After 4 weeks
After 8 weeks
Before use
After 4 weeks
After 8 weeks
Before use
After 4 weeks
After 8 weeks
Double Chin Lifting Volume Improvement
Double Chin Lifting Effect (Volume)
Clinical Trial Results
34.4%
Facial Area (Double Chin) 8 weeks of use
- Average age of clinical trial participants: 40 years oldBefore use
After 4 weeks
After 8 weeks
Before use
After 4 weeks
After 8 weeks
Dermis & Subcutaneous Fat Layer Boundary Length Reduction
Evaluation of Dermis and Subcutaneous Fat Layer Boundary Length
16.6%
Femoral Region (Thigh Area) used for 8 weeks
- average age of clinical trial participants: 36 years oldBefore use
After 4 weeks
After 8 weeks
Cellulite Reduction Visual Evaluation
Visual Evaluation of Temporary Cellulite Reduction Effect Results
7.2%
Femoral Region (Thigh Area) used for 8 weeks
- average age of clinical trial participants: 36 years oldBefore use
After 4 weeks
After 8 weeks
Skin Texture (Roughness) Improvement Effect
Improvement Evaluation of Skin Texture (Roughness) Results
6.1%
Femoral Region (Thigh Area) used for 8 weeks
- average age of clinical trial participants: 36 years oldBefore use
After 4 weeks
After 8 weeks